Wells Fargo Maintains Equal-Weight on Sherwin-Williams, Lowers Price Target to $250
Wells Fargo analyst Michael Sison maintains Sherwin-Williams (NYSE:SHW) with a Equal-Weight and lowers the price target from $270 to $250.
Credit Suisse Maintains Underperform on Sherwin-Williams, Lowers Price Target to $225
Credit Suisse analyst John Roberts maintains Sherwin-Williams (NYSE:SHW) with a Underperform and lowers the price target from $245 to $225.
Why This Healthcare Stock Dipped Over 75%; Here Are 73 Biggest Movers From Yesterday
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares climbed 53.2% to close at $3.14 on Wednesday. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital Medical Center for S&P vaccine platform development.
This Asset Management Stock Is Trading Higher By More Than 45%, Here Are 54 Stocks Moving In Wednesday’s Mid-Day Session
Gainers
Blue Water Vaccines, Inc. (NASDAQ: BWV) shares jumped 67.8% to $3.4390. Blue Water Vaccines recently announced signing of sponsored research agreement with Cincinnati Children's Hospital Medical Center for S&P vaccine platform development.
Sherwin-Williams Q2 EPS $2.41 Misses $2.78 Estimate, Sales $5.87B Miss $6.03B Estimate
Sherwin-Williams (NYSE:SHW) reported quarterly earnings of $2.41 per share which missed the analyst consensus estimate of $2.78 by 13.31 percent. This is a 9.06 percent decrease over earnings of $2.65 per share from the
Earnings Scheduled For July 27, 2022
Companies Reporting Before The Bell
• Equinor (NYSE:EQNR) is projected to report earnings for its second quarter.
Looking Into Sherwin-Williams’s Recent Short Interest
Sherwin-Williams's (NYSE:SHW) short percent of float has fallen 8.85% since its last report. The company recently reported that it has 2.82 million shares sold short, which is 3.4% of all regular shares that are available for trading.
Here’s How Much You Would Have Made Owning Sherwin-Williams Stock In The Last 10 Years
Sherwin-Williams (NYSE:SHW) has outperformed the market over the past 10 years by 7.63% on an annualized basis producing an average annual return of 18.72%. Currently, Sherwin-Williams has a market capitalization of $63.46 billion.
Mizuho Maintains Buy on Sherwin-Williams, Lowers Price Target to $294
Mizuho analyst Christopher Parkinson maintains Sherwin-Williams (NYSE:SHW) with a Buy and lowers the price target from $310 to $294.
B of A Securities Downgrades Sherwin-Williams to Neutral, Lowers Price Target to $292
B of A Securities analyst Steve Byrne downgrades Sherwin-Williams (NYSE:SHW) from Buy to Neutral and lowers the price target from $313 to $292.